Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04854668 |
| Consolidated Lead Sponsor | Chia Tai Tianqing Pharmaceutical Group Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 748 participants (ACTUAL) |
| Registered Start Date | 2021-05-27 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Fujian Medical University Union Hospital | Fuzhou, China | Open Hospital Dossier -> |
| Anhui Provincial Hospital | Hefei, China | Open Hospital Dossier -> |
| China-Japan Friendship Hospital | Beijing, China | Open Hospital Dossier -> |
| Beijing Friendship Hospital , Capital Medical University | Beijing, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.